Federated Hermes launches Federated Hermes MDT Market Neutral ETF
New product leverages MDT investment team's three decades of experience and skill PITTSBURGH, Sept. 25, 2025 /PRNewswire/ -- Federated Hermes,...
Morning Movers
CleanSpark Opens $100M Bitcoin-Backed Credit Facility with Two Prime
Proceeds to accelerate data center growth and support Digital Asset Management team's Bitcoin treasury monetization LAS VEGAS, Sept. 25, 2025...
Vanda Pharmaceuticals announces the publication in PLOS One of an article titled “Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial”
WASHINGTON, Sept. 25, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled...
AtlasClear Holdings Inc. Engages PCG Advisory to Enhance Investor Relations, Digital Communications and Market Visibility
Engagement Underscores Commitment to Strategic Communications and Investor Engagement TAMPA, Fla., Sept. 25, 2025 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc....
AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors
Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is...
Harmonic and Mediacom Mark Industry Milestone with Unified DOCSIS 4.0 Production Deployment on a Live Network
Speed Tests and Real-Time Analytics Shown at the Harmonic Booth atSCTE TechExpo25 Will Highlight Elevated Broadband Experiences Delivered toReal-World Customers...
Sienna Resources Inc. Renews All Nevada Lithium Claims as President Trump Looks to Take a Stake in Lithium Americas’ Thacker Pass Lithium Deposit in Nevada
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - Sienna Resources Inc. (TSXV: SIEN) (OTCID: SNNAF) (WKN: A418KR) (the "Company" or...
See essential dive data at a glance with the Descent X30 large-format dive computer from Garmin
Eco-friendly dive computer with a large, vivid display helps recreational divers explore with confidenceOLATHE, Kan., Sept. 25, 2025 /PRNewswire/ -- Garmin...
Safe & Green Holdings Announces Final Resolution of Litigation Between SG Blocks and EDI International/PVE
Miami, Florida--(Newsfile Corp. - September 25, 2025) - Safe & Green Holdings Corp. (NASDAQ: SGBX) ("Safe & Green," or the...
Equinix Unveils Distributed AI Infrastructure to Help Businesses Accelerate the Next Wave of AI Innovation
REDWOOD CITY, Calif., Sept. 25, 2025 /PRNewswire/ -- At its inaugural AI Summit, Equinix, Inc. (Nasdaq: EQIX), the world's digital infrastructure...
CONTANGO ORE ANNOUNCES $50 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
FAIRBANKS, Alaska, Sept. 25, 2025 /PRNewswire/ - Contango ORE, Inc. ("Contango" or the "Company") (NYSE American: CTGO), is pleased to...
Armlogi Holding Corp. Announces Its Fiscal 2025 Full-Year Financial Results
WALNUT, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing...
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors
Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors NEW YORK, Sept. 25, 2025 /PRNewswire/...
Leap Therapeutics to Present Final Clinical Data from Part B of the DeFianCe Study at the ESMO Congress 2025
CAMBRIDGE, Mass., Sept. 25, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and...
Avant Technologies, Inc. Bolsters Strategic Vision with Targeted Biotech Partnerships for Innovative Cell-Based Therapies
LAS VEGAS, Sept. 25, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), today announced a pivotal evolution...
Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
– Vidofludimus Calcium Demonstrated Statistically Significant 24-Week Confirmed Disability Improvement in Phase 2 CALLIPER Trial in Progressive Multiple Sclerosis, With...
Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A Common Stock to Sanofi
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer...
SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage...
Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”),...
Pure Storage’s Enterprise Data Cloud Unifies Data to Give Businesses Greater Control of their AI Initiatives
Enhancements to the Pure Storage Platform ensure data is accessible wherever it's needed with workload coverage expansion into the cloud...
Qatar Investment Authority and Blue Owl Capital Enter Agreement to Establish Digital Infrastructure Partnership
QIA and Blue Owl to collaborate to anchor a new permanent capital platform, further expanding Blue Owl's leading digital infrastructure...
Blue Sky Uranium Announces Registration of Mining Rights Transfer for Ivana Uranium-Vanadium Project, Argentina
TSX Venture Exchange: BSKFrankfurt Stock Exchange: MAL2OTCQB Venture Market (OTC): BKUCF VANCOUVER, BC, Sept. 25, 2025 /PRNewswire/ - Blue Sky Uranium...
Tungray Technologies Inc Announces Results of 2025 Annual General Meeting of Shareholders
SINGAPORE, Sept. 25, 2025 /PRNewswire/ -- Tungray Technologies Inc (Nasdaq: TRSG) (the "Company" or "TRSG"), a global Engineer-to-Order (ETO) company,...
Pure Storage Expands Cyber Resilience Through New Innovations and Deeper Partnerships So Organizations Can Stay Focused on Business
Expanded cyber risk capabilities improve organizations' ability to anticipate, address, and recover from today's most sophisticated cyber threats NEW YORK,...
DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest
Board forms Special Committee and engages Perella Weinberg Partners as financial advisor Company completed an oversubscribed $17.5 million private placement...
Cadiz Inc. Declares Quarterly Dividend for Q3 2025 on Series A Cumulative Perpetual Preferred Stock
LOS ANGELES, Sept. 24, 2025 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI / CDZIP) ("Cadiz," the "Company"), a California water solutions...
Quantum Computing Inc. Announces Closing of Oversubscribed Private Placement of Common Stock for Proceeds of $500 Million
The offering was led by several large existing shareholders alongside an initial investment from a preeminent global alternative asset manager...
Federal Signal to Acquire New Way Trucks; Expand Specialty Vehicle Platform into Refuse Collection Vehicles
DOWNERS GROVE, Ill., Sept. 24, 2025 /PRNewswire/ -- Federal Signal Corporation (NYSE: FSS) ("Federal Signal" or the "Company"), a leader...
PRA Group Announces Pricing of Offering of €300 Million of 6.250% Senior Notes due 2032
NORFOLK, Va., Sept. 24, 2025 /PRNewswire/ -- PRA Group, Inc. (Nasdaq: PRAA) (the "Company"), a global leader in acquiring and...
AZZ Inc. to Review Second Quarter Fiscal Year 2026 Financial Results on Thursday, October 9, 2025
FORT WORTH, Texas, Sept. 24, 2025 /PRNewswire/ -- AZZ Inc. (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and...
Pelangio Exploration Increases Size of Previously Announced Private Placement up to $4,500,000
Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Pelangio Exploration Inc. (TSXV: PX) (OTC Pink: PGXPF) ("Pelangio" or the "Company")...
EastGroup Properties Announces Third Quarter 2025 Earnings Conference Call and Webcast
JACKSON, Miss. , Sept. 24, 2025 /PRNewswire/ -- EastGroup Properties, Inc. (NYSE: EGP) (the "Company" or "EastGroup") announced today that it will...
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, Sept. 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its third quarter 2025 conference call for investors...
Invesco Mortgage Capital Inc. Announces Quarterly Common Dividend
ATLANTA, Sept. 24, 2025 /PRNewswire/ -- Invesco Mortgage Capital Inc. (the "Company") (NYSE: IVR) today announced that its Board of...
Invesco Mortgage Capital Inc. Announces Board Retirements and Changes
ATLANTA, Sept. 24, 2025 /PRNewswire/ -- Invesco Mortgage Capital Inc. (NYSE: IVR) (the "Company") announced the planned retirement of its Board...
Invesco Mortgage Capital Inc. Announces Quarterly Common Dividend
ATLANTA, Sept. 24, 2025 /PRNewswire/ -- Invesco Mortgage Capital Inc. (the "Company") (NYSE: IVR) today announced that its Board of...
Invesco Mortgage Capital Inc. Announces Board Retirements and Changes
ATLANTA, Sept. 24, 2025 /PRNewswire/ -- Invesco Mortgage Capital Inc. (NYSE: IVR) (the "Company") announced the planned retirement of its Board...
Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer...
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
- 86% overall survival (OS) observed at 9 months; standard of care benchmark is ~47% - - 53% progression-free survival...
PepGen Announces Proposed Public Offering
BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of...